Concepedia

Author

Ann‐Katrin Andersson

AstraZeneca (Sweden)

Also Known As

A. K. Andersson, A.-K. Andersson, Ann-Katrin Andersson, Ann‐Katrin Andersson

11

Publications

273

Citations

6

H-Index

16

Concepts

All Affiliations

AstraZeneca (Sweden)University of Gothenburg
AA

About

Ann‐Katrin Andersson is an author at AstraZeneca (Sweden) specializing in medicine, physiology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

59

2

Pharmacology

2

2

36

3

Health Sciences

1

1

25

4

Gastroenterology

1

1

25

5

Hepatology

1

1

25

Ann‐Katrin Andersson

×

6

Publications

271

Citations

6

H-Index

YearCitations

Role of ADAMTS-1 in Atherosclerosis

Ann‐Cathrine Jönsson‐Rylander, Tina Nilsson, Regina Fritsche‐Danielson,

Arteriosclerosis Thrombosis and Vascular Biology

2004

173

Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters

Agneta Karlsson, Åke Jägervall, Madeleine Pettersson,

International Immunopharmacology

2007

25

High-protein diet accelerates diabetes and kidney disease in the BTBR<i>ob/ob</i> mouse

Anna Granqvist, Anette Ericsson, José Sánchez,

American Journal of Physiology-Renal Physiology

2020

24

Calpains in Lens Epithelium from Patients with Cataract

Madeleine Andersson, Johan Sjöstrand, Ann‐Katrin Andersson,

Experimental Eye Research

1994

23

Changes in the soluble protein of the human vitreous in vitreoretinal disease

Johan Sjöstrand, Jan‐Olof Karlsson, Ann‐Katrin Andersson

Acta Ophthalmologica

1992

15

Cardiac-Specific Overexpression of Oxytocin Receptor Leads to Cardiomyopathy in Mice

Christian Jung, Bernhard Wernly, Mikael Bjursell,

Journal of Cardiac Failure

2018

11

Page 1